Diabetic foot ulceration represents a major complication of diabetes mellitus arising from a combination of peripheral neuropathy, vascular insufficiency and impaired wound healing. Management ...
Lakewood-Amedex Biotherapeutics Inc., (NASDAQ: LABT, the "Company"), a clinical-stage biotechnology company advancing a novel ...
SARASOTA, Fla., May 27, 2026 /PRNewswire/ -- Lakewood-Amedex Biotherapeutics Inc., (NASDAQ: LABT, the "Company"), a clinical-stage biotechnology company advancing a novel class of potent, fast-acting, ...
The photo of the patient's foot, sent from his campsite, included a cheeky note: "I remember you telling me that getting in trouble doing something was better than getting in trouble doing nothing.
May 23, 2012 — Correct multidisciplinary treatment of common diabetic foot infections can reduce amputations, according to guidelines for diagnosis and treatment issued by the Infectious Diseases ...
A recent ACS Pharmacology & Translational Science study examined the biogenic amines and small-molecule metabolites in diabetic foot ulcer (DFU) wound exudates to identify their potential roles in ...
Two prospective cohorts (n = 39) enrolled chronic infected diabetic ulcers nonresponsive to ≥ 3 months of standard care, with frequent assessments (~3 visits/week) and outcomes spanning closure, ...
Adding topical esmolol hydrochloride to standard of care (SOC) significantly improved healing of diabetic foot ulcers, a phase III randomized trial from India showed. During a 12-week treatment phase, ...
Leading clinician and surgeon to also serve as Scientific Advisor for Lakewood-Amedex Biotherapeutics' iDFU program SARASOTA, Fla., June 25, 2026 /PRNewswire/ -- Lakewood-Amedex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results